|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dünne AA, Müller HH, Eisele DW, Kessel K,
Moll R and Werner JA: Meta-analysis of the prognostic significance
of perinodal spread in head and neck squamous cell carcinomas
(HNSCC) patients. Eur J Cancer. 42:1863–1868. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xing Y, Zhang J, Lin H, Gold KA, Sturgis
EM, Garden AS, Lee JJ and William WN Jr: Relation between the level
of lymph node metastasis and survival in locally advanced head and
neck squamous cell carcinoma. Cancer. 122:534–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bachelerie F, Ben-Baruch A, Burkhardt AM,
Combadiere C, Farber JM, Graham GJ, Horuk R, Sparre-Ulrich AH,
Locati M, Luster AD, et al: International union of basic and
clinical pharmacology. [corrected]. LXXXIX. Update on the extended
family of chemokine receptors and introducing a new nomenclature
for atypical chemokine receptors. Pharmacol Rev. 66:1–79. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J, Wang S, Zhao G and Sun B: Effect
of chemokine receptors CCR7 on disseminated behavior of human T
cell lymphoma: Clinical and experimental study. J Exp Clin Cancer
Res. 30:512011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Förster R, Schubel A, Breitfeld D, Kremmer
E, Renner-Müller I, Wolf E and Lipp M: CCR7 coordinates the primary
immune response by establishing functional microenvironments in
secondary lymphoid organs. Cell 1999.99: 23–33. J Immunol.
196:5–15. 2016.PubMed/NCBI
|
|
7
|
Wang J, Xi L, Hunt JL, Gooding W,
Whiteside TL, Chen Z, Godfrey TE and Ferris RL: Expression pattern
of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma
of the head and neck identifies a novel metastatic phenotype.
Cancer Res. 64:1861–1866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through MAPKs in metastatic squamous cell carcinoma of head and
neck. Int J Oncol. 45:2502–2510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao ZJ, Liu FY, Li P, Ding X, Zong ZH and
Sun CF: CCL19-induced chemokine receptor 7 activates the
phosphoinositide-3 kinase-mediated invasive pathway through Cdc42
in metastatic squamous cell carcinoma of the head and neck. Oncol
Rep. 25:729–737. 2011.PubMed/NCBI
|
|
10
|
Chekulaeva M and Filipowicz W: Mechanisms
of miRNA-mediated post-transcriptional regulation in animal cells.
Curr Opin Cell Biol. 21:452–460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ambros V and Lee RC: Identification of
microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods
Mol Biol. 265:131–158. 2004.PubMed/NCBI
|
|
12
|
Volinia S, Galasso M, Sana ME, Wise TF,
Palatini J, Huebner K and Croce CM: Breast cancer signatures for
invasiveness and prognosis defined by deep sequencing of microRNA.
Proc Natl Acad Sci USA. 109:3024–3029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Olena AF and Patton JG: Genomic
organization of microRNAs. J Cell Physiol. 222:540–545.
2010.PubMed/NCBI
|
|
14
|
Park NJ, Zhou H, Elashoff D, Henson BS,
Kastratovic DA, Abemayor E and Wong DT: Salivary microRNA:
Discovery, characterization, and clinical utility for oral cancer
detection. Clin Cancer Res. 15:5473–5477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishida N, Mimori K, Fabbri M, Yokobori T,
Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y and Mori M:
MicroRNA-125a-5p is an independent prognostic factor in gastric
cancer and inhibits the proliferation of human gastric cancer cells
in combination with trastuzumab. Clin Cancer Res. 17:2725–2733.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Janiszewska J, Szaumkessel M and Szyfter
K: MicroRNAs are important players in head and neck carcinoma: A
review. Crit Rev Oncol Hematol. 88:716–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
National Comprehensive Cancer Network, .
Head and Neck Cancer. (Version 1.2017). https://www.nccn.org/professionals/physician_gls/#siteFebruary
1–2017
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okamoto K, Miyoshi K and Murawaki Y:
miR-29b, miR-205 and miR-221 enhance chemosensitivity to
gemcitabine in HuH28 human cholangiocarcinoma cells. PloS One.
8:e776232013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Volinia S, Galasso M, Costinean S,
Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N,
Sana ME, Jarour Abu R, et al: Reprogramming of miRNA networks in
cancer and leukemia. Genome Res. 20:589–599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liang Y, Ridzon D, Wong L and Chen C:
Characterization of microRNA expression profiles in normal human
tissues. BMC Genomics. 8:1662007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramdas L, Giri U, Ashorn CL, Coombes KR,
El-Naggar A, Ang KK and Story MD: MiRNA expression profiles in head
and neck squamous cell carcinoma and adjacent normal tissue. Head
Neck. 31:642–654. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hui AB, Lenarduzzi M, Krushel T, Waldron
L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B,
Waldron J, et al: Comprehensive MicroRNA profiling for head and
neck squamous cell carcinomas. Clin Cancer Res. 16:1129–1139. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang L, Huang Q, Zhang S, Zhang Q, Chang
J, Qiu X and Wang E: Hsa-miR-125a-3p and hsa-miR-125a-5p are
downregulated in non-small cell lung cancer and have inverse
effects on invasion and migration of lung cancer cells. BMC Cancer.
10:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tiwari A, Shivananda S, Gopinath KS and
Kumar A: MicroRNA-125a reduces proliferation and invasion of oral
squamous cell carcinoma cells by targeting estrogen-related
receptor alpha: Implications for cancer therapeutics. J Biol Chem.
289:32276–32290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu FY, Safdar J, Li ZN, Fang QG, Zhang X,
Xu ZF and Sun CF: CCR7 regulates cell migration and invasion
through JAK2/STAT3 in metastatic squamous cell carcinoma of the
head and neck. Biomed Res Int. 2014:4153752014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo N, Liu F, Yang L, Huang J, Ding X and
Sun C: Chemokine receptor 7 enhances cell chemotaxis and migration
of metastatic squamous cell carcinoma of head and neck through
activation of matrix metalloproteinase-9. Oncol Rep. 32:794–800.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan J, Xiao G, Peng G, Liu D, Wang Z,
Liao Y, Liu Q, Wu M and Yuan X: MiRNA-125a-5p inhibits glioblastoma
cell proliferation and promotes cell differentiation by targeting
TAZ. Biochem Biophys Res Commun. 457:171–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Khan AA, Betel D, Miller ML, Sander C,
Leslie CS and Marks DS: Transfection of small RNAs globally
perturbs gene regulation by endogenous microRNAs. Nat Biotechnol.
27:549–555. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008. View Article : Google Scholar : PubMed/NCBI
|
